Business ❯ Pharmaceuticals ❯ Drug Development

Oncology

Clinical Trials Acute Myeloid Leukemia Checkpoint Therapeutics Therapies KRAS G12D Inhibitors ISB 2001 HER2-positive Cancer KRAS Inhibitors Prostate Cancer Partnerships Precision Medicine Collaboration Agreements Chronic Lymphocytic Leukaemia Lung Cancer

AstraZeneca Licenses Global Rights to Zegfrovy From Dizal

The deal gives AstraZeneca the commercial scale to broaden access to the EGFR exon 20 insertion drug while first-line approval reviews continue.

Roche and Nurix Strike $700M Deal to Co‑Develop Oral BTK Degrader Bexobrutideg

Pfizer and Innovent Strike Up to $10.5 Billion Oncology Collaboration

Bristol Myers and Hengrui Ink Up to $15.2 Billion Drug Discovery Alliance

Astellas–Vir Prostate Cancer Alliance Launches With New Data as VIR Stock Surges